5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Clinical trial NCT01038635 · COMPLETED
Trial details
- NCT number
- NCT01038635
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2015-11-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.